Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 4/2005

01-08-2005 | LETTER TO THE EDITOR

Multiseptate gallbladder: MR and MR cholangiographic findings

Authors: E. Kocakoc, A. Kiris, Z. Bozgeyik

Published in: Abdominal Radiology | Issue 4/2005

Login to get access

Excerpt

We read with interest the recent case report by Nakazawa et al. entitled “Multiseptate gallbladder: diagnostic value of MR cholangiography and ultrasonography” in the November/December issue of Abdominal Imaging [1]. …
Literature
1.
Nakazawa T, Ohara H, Sano H, et al. Multiseptate gallbladder: diagnostic value of MR cholangiography and ultrasonography. Abdom Imaging 2004;29:691–693CrossRefPubMed
2.
Kocakoc E, Kiris A, Alkan A, et al. Multiseptate gallbladder in a child with chronic abdominal pain: ultrasonography, magnetic resonance imaging and magnetic resonance cholangiography findings. Eur J Radiol 2003;47(suppl):22–25CrossRef
Metadata
Title
Multiseptate gallbladder: MR and MR cholangiographic findings
Authors
E. Kocakoc
A. Kiris
Z. Bozgeyik
Publication date
01-08-2005
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 4/2005
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-005-0332-6

Other articles of this Issue 4/2005

Abdominal Radiology 4/2005 Go to the issue

OriginalPaper

Radiofrequency ablation of neuroendocrine liver metastases—the Middlesex experience

OriginalPaper

Radiofrequency ablation of neuroendocrine liver metastases

OriginalPaper

Radiofrequency ablation of renal cell carcinoma

OriginalPaper

Book review

OriginalPaper

Radiofrequency ablation: other abdominal organs

OriginalPaper

Pancreatic head cancer: accuracy of CT in determination of resectability
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits